We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWH icon
826
Camping World
CWH
$654M
$931K 0.01%
+31,287
New +$1.02M
ERIC icon
827
Ericsson
ERIC
$33B
$928K 0.01%
85,220
-36,288
-30% -$401K
GMED icon
828
Globus Medical
GMED
$11.5B
$923K 0.01%
+18,626
New +$961K
CRUS icon
829
Cirrus Logic
CRUS
$6.11B
$902K 0.01%
13,373
+7,376
+123% +$462K
TTEC icon
830
TTEC Holdings
TTEC
$83.2M
$902K 0.01%
16,530
-73,748
-82% -$3.88M
CSII
831
DELISTED
Cardiovascular Systems, Inc.
CSII
$899K 0.01%
22,884
+12,948
+130% +$418K
SPLK
832
DELISTED
Splunk Inc
SPLK
$891K 0.01%
4,736
-581
-11% -$116K
VRT icon
833
Vertiv
VRT
$108B
$885K 0.01%
+51,060
New +$799K
VTR icon
834
Ventas
VTR
$45.5B
$881K 0.01%
+21,003
New +$840K
SUPN icon
835
Supernus Pharmaceuticals
SUPN
$2.79B
$880K 0.01%
42,185
-81,547
-66% -$1.85M
ARCO icon
836
Arcos Dorados Holdings
ARCO
$1.68B
$874K 0.01%
215,895
-3,122
-1% -$14K
FTDR icon
837
Frontdoor
FTDR
$5.87B
$874K 0.01%
+22,493
New +$960K
AEO icon
838
American Eagle Outfitters
AEO
$2.93B
$867K 0.01%
58,574
+8,199
+16% +$97.8K
DYN icon
839
Dyne Therapeutics
DYN
$4.94B
$861K 0.01%
+42,623
New +$935K
SSRM icon
840
SSR Mining
SSRM
$6.47B
$852K 0.01%
45,627
+9,185
+25% +$196K
LSTR icon
841
Landstar System
LSTR
$6B
$848K 0.01%
+6,754
New +$850K
CALC icon
842
CalciMedica
CALC
$10.3M
$846K 0.01%
+4,758
New +$992K
SPT icon
843
Sprout Social
SPT
$617M
$840K 0.01%
21,819
-101,532
-82% -$3.22M
ORPH
844
DELISTED
Orphazyme A/S
ORPH
$840K 0.01%
+81,332
New +$815K
PB icon
845
Prosperity Bancshares
PB
$8.88B
$832K 0.01%
16,051
-49,032
-75% -$2.69M
TPL icon
846
Texas Pacific Land
TPL
$24.5B
$828K 0.01%
16,515
+12,744
+338% +$761K
GLUU
847
DELISTED
Glu Mobile Inc.
GLUU
$820K 0.01%
106,851
-141,314
-57% -$1.19M
BHC icon
848
Bausch Health
BHC
$2.33B
$818K 0.01%
52,661
-38,430
-42% -$662K
PM icon
849
Philip Morris
PM
$291B
$816K 0.01%
+10,884
New +$840K
FLY
850
DELISTED
Fly Leasing Limited
FLY
$816K 0.01%
+112,370
New +$812K

Similar funds

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.